AnandaBasuMD

Endocrinology • Birmingham, AL

Diabetes, Lipid Metabolism

Professor, Family Medicine, Mayo Medical School

Join to view full profile

Dr. Basu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Basu's full profile

Already have an account?

Office
2000 6th Ave S
Birmingham, AL 35233
Phone+1 205-934-9999

Fax+1 434-972-4266

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1994 - 1997
Mayo Clinic College of MedicineClass of 1985

Certifications & Licensure

AL State Medical License 2023 - 2025
VA State Medical License 2017 - 2024
MN State Medical License 1997 - 2017
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes Start of enrollment: 2010 Feb 01
Completed
USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes Start of enrollment: 2014 Jun 01
Completed
Not Applicable
At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation Start of enrollment: 2016 Feb 01
Completed
Phase 3

Publications & Presentations

PubMed

Young‐onset diabetes, nutritional therapy and novel insulin delivery systems: a report from the 21st Hong Kong Diabetes and Cardiovascular Risk Factors – East Meets We...
Andrea O.Y. Luk, Alice P.S. Kong, Ananda Basu
Diabetic Medicine. 2020-06-08
18 citations
Beyond HbA1c : using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making.
Sue A. Brown, Ananda Basu, B Kovatchev
Diabetic Medicine. 2019-06-01
21 citations
Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice
Minglin Pan, Ying Han, Aninda Basu, Anzhi Dai, Rui Si
American Journal of Physiology. Cell Physiology. 2018-06-01

Journal Articles

Paradigm Shifts in Nocturnal Glucose Control in Type 2 Diabetes
Robert A Rizza, Ananda Basu, Rita Basu, The Journal of Clinical Endocrinology and Metabolism

Lectures

Differential Regulation of Glucocorticoids and Insulin on Hepatic 11ß-Hydroxysteroid Dehydrogenase Type 1 Enzyme Activity
Rochester, MN - 6/16/2014
Glucagon-Like Peptide 1 Modulates Reductions in Myocardial Blood Flow Reserve during Euglycemia and Hyperglycemia in Both Type 2 Diabetics and Non-Diabetics
Rochester, MN - 6/15/2014